patents

Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

CellaVision acquires exclusive rights to novel microscopy technology

By AWA | Posted on April 8, 2021

AWA’s client CellaVision has signed an agreement to acquire the exclusive rights to a patent portfolio on Fourier Ptychographic Microscopy, a novel microscopy technology from Clearbridge BioPhotonics. CellaVision is an innovative, global medical technology company that develops and sells leading systems for routine analysis of blood and other body fluids in health care services. AWA...

Tags: CellaVision, due dilligence, patents

EPO releases Patent Index 2020: Applications stable despite pandemic, healthcare innovation soars and the US tops geographic origin of applications outside of Europe

By AWA | Posted on March 18, 2021

The European Patent Office (EPO) released its Patent Index 2020 this week. Despite the coronavirus pandemic, filings remained stable with increases in applications from the medical technology, biotechnology and pharmaceutical industries. These increases helped to counter declines seen in some sectors like mechanical engineering. Top Industries As a result of the current global situation, it...

Tags: EPO, Patent Innovation Index 2020, patents

All eyes on Germany as UPC is resuscitated at Bundestag and Bundesrat

By Louise Jonshammar | Posted on December 18, 2020

German ratification of the UPCA is one of the last hurdles for the Unitary Patent system. The system has suffered a series of delays ever since an agreement was reached in 2012 that made the Unitary Patent possible through enhanced cooperation at an EU-level. The Unitary Patent system aims to provide easier and affordable access...

Tags: Bundesrat, EU, Europe, European patents, Germany, patents, unitary patent, UPC, UPCA

China introduces compensation for patent terms

By AWA | Posted on December 15, 2020

On October 17, 2020, the Standing Committee of the 13th National People’s Congress passed amendments to the PRC Patent Law, which come into force June 1, 2021. The amendments cover three key areas: 1) Strengthening the protection of the legitimate rights and interests of patentees; 2) Promoting the implementation and application of patents; and 3)...

Tags: china, compensation, innovative drugs, patent terms, patents

Protecting Biological Drug Innovations

By AWA | Posted on November 11, 2020

Learn how to protect biological drug innovations during this webinar from Stockholm Science City (In Swedish). Ulrika Munter and Nora Spjuth share their experiences working with intellectual property in this field and Linus Plym Forshell from the Swedish Intellectual Property Office (PRV) provides an overview of IP strategies in the pharmaceutical sector. This webinar is in Swedish. 

Tags: biological, drugs, innovations, patents, PRV

EU requires manufacturers to disclose scientific documents during risk assessment for food chain production

By Eric Van Malderen | Posted on September 30, 2020

The European Food Safety Agency (EFSA) is in charge of the registration into the European Union of novel foods and feeds, food and feed additives, food and feed contact materials, GMO’s, plant protection products, food and feed enzymes as well as food and feed flavourings. To increase the legitimacy and credibility of their opinions, food...

Tags: EFSA, EU, European Union, Food, Manufacturing, patents, trade secrets

Patenting Antibody and Cell Therapies – What to Do and What Not to Do

By Joanna Applequist, Louise Jonshammar, Niklas Mattsson | Posted on September 28, 2020

Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great promise when it comes to curing disease and helping patients, but also in creating value and growth. Biotech companies need to protect their scientific results and the corresponding investments with strong and durable patents. This is...

Tags: antibodies, Biotechnology, cell therapies, EPO, Litigation, patents

Easing the Pain for SMEs – Effectiveness of External IP Counsel

By AWA | Posted on August 31, 2020

In this interactive webinar moderated by Cathrin Johansson, panellists Malin Wennberg and Anneli Jönsson take a closer look at some of the IP challenges facing SMEs and how utilising external IP counsel can help to ease the pain. They provide hands-on advice from experiences where AWA has acted as an in-house IP department or external...

Tags: IP, patents, SMEs, strategy, webinar

Recent contributors

Laura Stravinskaite

Laura Stravinskaite

Senior Associate, Attorney at Law

Ai-Leen Lim

Ai-Leen Lim

Partner, Attorney at Law, Group Vice President

Ashley Zhao

Ashley Zhao

Partner, Attorney at Law, Business Area Manager

Troels Peter Rørdam

Troels Peter Rørdam

Senior Counsel, European Patent Attorney

Mikkel Roed Trier

Mikkel Roed Trier

Partner, European Patent Attorney, UPC Representative, Business Area Manager